89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010/LEAP-010)-China Extension
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
Real-time Margin Assessment in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
The Use of "Smart" Body-Weight Scales for Weight and Nutritional Monitoring in Patients With Head and Neck Cancer Undergoing Radiation Therapy
- Status
- TERMINATED
- Phase
- NA
Sodium Selenite Supplementation in Patients With Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- NA
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC
- Status
- RECRUITING
- Phase
- NA
Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung
- Status
- WITHDRAWN
- Phase
- NA